Hologic Historical Cash Flow
| HOLX Stock | USD 79.50 0.06 0.08% |
Analysis of Hologic cash flow over time is an excellent tool to project Hologic future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 2.9 B or Depreciation of 217.6 M as it is a great indicator of Hologic ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Hologic latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hologic is a good buy for the upcoming year.
Hologic |
About Hologic Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Hologic balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Hologic's non-liquid assets can be easily converted into cash.
Hologic Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Hologic's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Cash And Cash Equivalents Changes is fairly stable compared to the past year. Cash Flows Other Operating is likely to rise to about 383.8 M in 2024, despite the fact that Change To Inventory is likely to grow to (45 M).
Hologic cash flow statement Correlations
Click cells to compare fundamentals
Hologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hologic cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (25.3M) | (84.1M) | (136.6M) | (4.9M) | (47.4M) | (45.0M) | |
| Change In Cash | 99.2M | 469.3M | 1.2B | 416.2M | (595.5M) | (565.7M) | |
| Free Cash Flow | 740.2M | 2.2B | 2.0B | 901M | 1.2B | 1.3B | |
| Change In Working Capital | (636.3M) | 13M | 454.2M | 11.8M | 84.1M | 88.3M | |
| Begin Period Cash Flow | 601.8M | 701M | 1.2B | 2.3B | 2.8B | 2.9B | |
| Other Cashflows From Financing Activities | 791.2M | 1.2B | (1.6M) | 10.6M | (20M) | (19M) | |
| Depreciation | 376M | 406.9M | 430.1M | 323.4M | 309M | 217.6M | |
| Other Non Cash Items | 57.5M | 45.9M | 38.9M | 289.5M | 92.4M | 87.8M | |
| Capital Expenditures | 156.4M | 162.7M | 127.2M | 150.2M | 130.2M | 136.7M | |
| Total Cash From Operating Activities | 896.6M | 2.3B | 2.1B | 1.1B | 1.3B | 1.3B | |
| Net Income | 1.1B | 1.9B | 1.3B | 456M | 789.5M | 829.0M | |
| End Period Cash Flow | 701M | 1.2B | 2.3B | 2.8B | 2.2B | 2.3B | |
| Total Cash From Financing Activities | (659.9M) | (529.8M) | (756M) | (483.2M) | (1.1B) | (1.1B) | |
| Sale Purchase Of Stock | (653.6M) | (409.7M) | (542.1M) | (474.8M) | (835.1M) | (793.3M) | |
| Change To Account Receivables | (427.1M) | 110.9M | 272.3M | (1.5M) | 41M | 43.1M | |
| Change To Liabilities | 106.1M | 34.4M | (26.7M) | (8.6M) | (9.9M) | (9.4M) | |
| Total Cashflows From Investing Activities | (141.6M) | (1.3B) | (206.3M) | (152.1M) | (174.9M) | (183.7M) | |
| Other Cashflows From Investing Activities | (43.3M) | (2.2M) | 79.5M | 13.1M | 11.8M | 11.2M | |
| Investments | (141.6M) | (1.3B) | (206.3M) | (152.1M) | (136.9M) | (143.7M) | |
| Net Borrowings | (23.2M) | (113.4M) | (212.3M) | (19M) | (17.1M) | (16.2M) | |
| Dividends Paid | 33.2M | 49.8M | 65.6M | 51.3M | 59.0M | 71.5M | |
| Change To Netincome | 16.2M | 39M | (60.6M) | 260M | 234M | 168.3M | |
| Change To Operating Activities | (190.2M) | (61.2M) | 368.5M | 9.4M | 10.8M | 10.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.